Role of Genetic Testing in Kidney Stone Disease: A Narrative Review
Authors:
Open Access
- 3 August 2024
- journal article
- review article
- Published by Springer Nature in Current Urology Reports
- Vol. 25 (12) , 311-323
Abstract
Purpose of Review: Kidney stone disease (KSD) is a common and potentially life-threatening condition, and half of patients experience a repeat kidney stone episode within 5–10 years. Despite the ~50% estimate heritability of KSD, international guidelines have not kept up with the pace of discovery of genetic causes of KSD. The European Association of Urology guidelines lists 7 genetic causes of KSD as ‘high risk’. Recent Findings: There are currently 46 known monogenic (single gene) causes of kidney stone disease, with evidence of association in a further 23 genes. There is also evidence for polygenic risk of developing KSD. Evidence is lacking for recurrent disease, and only one genome wide association study has investigated this phenomenon, identifying two associated genes (SLC34A1 and TRPV5). However, in the absence of other evidence, patients with genetic predisposition to KSD should be treated as ‘high risk’. Further studies are needed to characterize both monogenic and polygenic associations with recurrent disease, to allow for appropriate risk stratification. Durability of test result must be balanced against cost. This would enable retrospective analysis if no genetic cause was found initially. Summary: We recommend genetic testing using a gene panel for all children, adults < 25 years, and older patients who have factors associated with high risk disease within the context of a wider metabolic evaluation. Those with a genetic predisposition should be managed via a multi-disciplinary team approach including urologists, radiologists, nephrologists, clinical geneticists and chemical pathologists. This will enable appropriate follow-up, counselling and potentially prophylaxis.Keywords
Funding Information
- Royal College of Surgeons of England
- Medical Research Council (MR/W03168X/1)
- NIHR Oxford Biomedical Research Centre (NF-SI-0514–10091)
- Wellcome Trust (204826/z/16/z)
- Kidney Research UK (RP_030_20180306)
This publication has 71 references indexed in Scilit:
- Genetic testing in children with nephrolithiasis and nephrocalcinosisPediatric Nephrology, 2023
- Systematic assessment of monogenic etiology in adult‐onset kidney stone formers undergoing urological intervention–evidence for genetic pretest probabilityAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohortMolecular Genetics and Genomics, 2022
- Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone DiseaseKidney International Reports, 2021
- Randomized Controlled TrialsChest, 2020
- Fluid Intake and Dietary Factors and the Risk of Incident Kidney Stones in UK Biobank: A Population-based Prospective Cohort StudyEuropean Urology Focus, 2020
- A Twin Study of Genetic Influences on Nephrolithiasis in Women and MenKidney International Reports, 2019
- Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH casesJournal of Applied Genetics, 2017
- A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiencyPediatric Nephrology, 2010
- Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidismCell, 1993